471 related articles for article (PubMed ID: 18439836)
21. A bystander effect observed in boron neutron capture therapy: a study of the induction of mutations in the HPRT locus.
Kinashi Y; Masunaga S; Nagata K; Suzuki M; Takahashi S; Ono K
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):508-14. PubMed ID: 17418970
[TBL] [Abstract][Full Text] [Related]
22. RBE in fast neutron therapy and in boron neutron capture therapy. A useful concept or a misuse?
Wambersie A; Menzel HG
Strahlenther Onkol; 1993 Jan; 169(1):57-64. PubMed ID: 8434341
[TBL] [Abstract][Full Text] [Related]
23. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Tjarks W; Lorey DR; Barth RF
J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
[TBL] [Abstract][Full Text] [Related]
24. [Superimposition alpha-autoradiography for basic study of neutron capture therapy (author's transl)].
Amano K
No To Shinkei; 1981 Jul; 33(7):693-701. PubMed ID: 7272098
[TBL] [Abstract][Full Text] [Related]
25. Radiobiological considerations concerning the development of compounds for boron neutron capture therapy.
Gabel D
Strahlenther Onkol; 1993 Jan; 169(1):65-70. PubMed ID: 8434342
[TBL] [Abstract][Full Text] [Related]
26. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography.
Yanagië H; Ogura K; Takagi K; Maruyama K; Matsumoto T; Sakurai Y; Skvarc J; Illic R; Kuhne G; Hisa T; Yoshizaki I; Kono K; Furuya Y; Sugiyama H; Kobayashi H; Ono K; Nakagawa K; Eriguchi M
Appl Radiat Isot; 2004 Oct; 61(4):639-46. PubMed ID: 15246411
[TBL] [Abstract][Full Text] [Related]
28. Combined TL and 10B-alanine ESR dosimetry for BNCT.
Bartolotta A; D'Oca MC; Lo Giudice B; Brai M; Borio R; Forini N; Salvadori P; Manera S
Radiat Prot Dosimetry; 2004; 110(1-4):627-30. PubMed ID: 15353720
[TBL] [Abstract][Full Text] [Related]
29. Extension of the calibration curve for the PGRA facility in Petten.
Nievaart S; Appelman K; Stecher-Rasmussen F; Sauerwein W; Wittig A; Moss R
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S362-4. PubMed ID: 19372039
[TBL] [Abstract][Full Text] [Related]
30. The radiobiological principles of boron neutron capture therapy: a critical review.
Hopewell JW; Morris GM; Schwint A; Coderre JA
Appl Radiat Isot; 2011 Dec; 69(12):1756-9. PubMed ID: 21543233
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro evaluation of the phenylboric acid derivative entrapped lipiodol in boron neutron capture therapy for hepatoma.
Chou FI; Chung HP; Shieh MS; Huang CW; Chung RJ; Liu HM; Yang JY; Chi CW; Lin YC; Lui WY; Kai JJ
Anticancer Res; 2003; 23(5A):3955-63. PubMed ID: 14666703
[TBL] [Abstract][Full Text] [Related]
32. Toward prompt gamma spectrometry for monitoring boron distributions during extra corporal treatment of liver metastases by boron neutron capture therapy: a Monte Carlo simulation study.
Khelifi R; Nievaart VA; Bode P; Moss RL; Krijger GC
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S359-61. PubMed ID: 19394243
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo studies of boron neutron capture therapy: boron uptake/washout and cell death.
Ferrari C; Bakeine J; Ballarini F; Boninella A; Bortolussi S; Bruschi P; Cansolino L; Clerici AM; Coppola A; Di Liberto R; Dionigi P; Protti N; Stella S; Zonta A; Zonta C; Altieri S
Radiat Res; 2011 Apr; 175(4):452-62. PubMed ID: 21133762
[TBL] [Abstract][Full Text] [Related]
34. Preliminary study for application of anti-alpha-fetoprotein monoclonal antibody to boron-neutron capture therapy.
Takahashi T; Fujii Y; Fujii G; Nariuchi H
Jpn J Exp Med; 1987 Apr; 57(2):83-91. PubMed ID: 2444730
[TBL] [Abstract][Full Text] [Related]
35. Neutron autoradiographic determination of boron-10 concentration and distribution in mammalian tissue.
Fairchild RG; Tonna EA; Seibold CT; Straub RF
Radiat Res; 1968 Oct; 36(1):87-97. PubMed ID: 17387929
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
[TBL] [Abstract][Full Text] [Related]
37. Selective radiography of 10B distribution in organs using cold and thermal neutron beams.
Skvarc J; Giacomelli M; Yanagië H; Kühne G
Cell Mol Biol Lett; 2002; 7(1):162-4. PubMed ID: 11944078
[TBL] [Abstract][Full Text] [Related]
38. The compound factor of the 10B(n,alpha)7Li reaction from borocaptate sodium and the relative biological effectiveness of recoil protons for induction of brain damage in boron neutron capture therapy.
Gabel D; Philipp KH; Wheeler FJ; Huiskamp R
Radiat Res; 1998 Apr; 149(4):378-86. PubMed ID: 9525503
[TBL] [Abstract][Full Text] [Related]
39. EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation.
Kullberg EB; Wei Q; Capala J; Giusti V; Malmström PU; Gedda L
Int J Radiat Biol; 2005 Aug; 81(8):621-9. PubMed ID: 16298943
[TBL] [Abstract][Full Text] [Related]
40. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
